Clinical Trials Directory

Trials / Completed

CompletedNCT03111927

Infant Nutrition and Brain Development

The Effect of Myelin-Relevant Nutrients in Infant Formula on Brain Myelination and Cognitive Development

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
189 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
2 Weeks – 6 Weeks
Healthy volunteers
Accepted

Summary

Research study on the role of early life nutrition on brain and cognitive development during infancy and early childhood. Two blends of myelin-relevant nutrients at different levels were compared and a breastfed group was considered as epidemiological reference.

Detailed description

This nutritional intervention study involved assessments in both the mother and her infant. The mother was asked to complete self-report questionnaires and to undergo a brief cognitive assessment. If the mother was not breastfeeding, a study product was provided and was consumed by the infant daily up to 12 months of life. The study also involved magnetic resonance imaging (MRI) brain scans of the infant's brain while asleep as well as evaluation of cognitive outcomes, including general cognitive development, and social-emotional development. Once all trial subjects completed the 6-month timepoint (intervention part), an inferential statistical analysis of all data up to 6 months was performed. Product codes (blinding) were broken to compare groups and an appropriate operational framework was put in place to maintain the individual assignment unknown to the Sponsor and Sites until the end of the trial.

Conditions

Interventions

TypeNameDescription
OTHERInfant Formula: enriched level of myelin-relevant nutrientsFeeding with the assigned infant formula begun as soon as the child was enrolled in the study (from 2 weeks up to 5 weeks of life) and lasted up to 12 months of age (+/- 2 weeks). The volume of feed required by the child per day depended upon age, weight, and appetite. The product was given daily ad libitum to the child from enrollment up to 12 months.
OTHERInfant formula: standard level of myelin-relevant nutrientsFeeding with the assigned infant formula begun as soon as the child was enrolled in the study (from 2 weeks up to 5 weeks of life) and lasted up to 12 months of age (+/- 2 weeks). The volume of feed required by the child per day depended upon age, weight, and appetite. The product was given daily ad libitum to the child from enrollment up to 12 months.

Timeline

Start date
2017-03-13
Primary completion
2021-02-28
Completion
2022-02-28
First posted
2017-04-13
Last updated
2022-07-21

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03111927. Inclusion in this directory is not an endorsement.